Altaf A. Dar
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
-
- Circular RNAs in diseases 10
- Protein Degradation and Inhibitors 4
- Melanoma and MAPK Pathways 4
- Ubiquitin and proteasome pathways 3
-
- MicroRNA in disease regulation 18
- Cancer-related molecular mechanisms research 12
- Co-authors
- Shahana Majid (26 shared papers)Rajvir Dahiya (20 shared papers)Sharanjot Saini (20 shared papers)Wael El‐Rifai (8 shared papers)Soichiro Yamamura (19 shared papers)Yuichiro Tanaka (16 shared papers)Guoren Deng (14 shared papers)Mohammed Kashani–Sabet (21 shared papers)
- Journals
- Cancer Research (12 papers)Proceedings of the National Academy of Sciences (4 papers)Clinical Cancer Research (3 papers)Cancer (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Altaf A. Dar
50 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 1.1k
- Molecular Biology 1.7k
- Oncology 524
- Cell Biology 313
- Pathology and Forensic Medicine 157
Countries citing papers authored by Altaf A. Dar
This map shows the geographic impact of Altaf A. Dar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Altaf A. Dar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Altaf A. Dar more than expected).
Fields of papers citing papers by Altaf A. Dar
This network shows the impact of papers produced by Altaf A. Dar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Altaf A. Dar. The network helps show where Altaf A. Dar may publish in the future.
Co-authors
The 25 scholars most cited alongside Altaf A. Dar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 243 | |
| 2 | 2010 | 213 | |
| 3 | 2011 | 202 | |
| 4 | 2009 | 143 | |
| 5 | 2012 | 126 | |
| 6 | 2011 | 120 | |
| 7 | 2010 | 117 | |
| 8 | 2017 | 109 | |
| 9 | 2013 | 106 | |
| 10 | 2008 | 104 | |
| 11 | 2012 | 97 | |
| 12 | 2008 | 96 | |
| 13 | 2013 | 93 | |
| 14 | 2008 | 73 | |
| 15 | 2015 | 69 | |
| 16 | 2020 | 63 | |
| 17 | 2016 | 55 | |
| 18 | 2012 | 54 | |
| 19 | 2019 | 40 | |
| 20 | 2008 | 37 |
About Altaf A. Dar
Altaf A. Dar is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 51 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (10 papers), Protein Degradation and Inhibitors (4 papers), Cancer-related Molecular Pathways (4 papers), Melanoma and MAPK Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.7k citations), Oncology (524 citations), Cell Biology (313 citations) and Pathology and Forensic Medicine (157 citations). Altaf A. Dar has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Shahana Majid, Rajvir Dahiya, Sharanjot Saini, Wael El‐Rifai, Soichiro Yamamura, Yuichiro Tanaka, Guoren Deng, Mohammed Kashani–Sabet, Mehdi Nosrati and Varahram Shahryari. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Clinical Cancer Research, Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.